TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ACHV

Achieve Life Sciences Inc

Healthcare · Biotechnology

7.80$ -3.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Achieve Life Sciences Inc (ACHV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 190 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACHV
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
24 19 70 65 48 39 27 59 52 42 33 190
22 17 68 63 46 36 25 57 50 40 31 188
20 16 66 15 9.5 13 13 52 32 21 28 48
20 16 66 61 43 34 23 55 48 36 29 187
0.1 0.1 – – – – – – – – – –
0.1 – – – – – – – – – – –
1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1.3 1.2 1.1 1.1 1.0 1.0 0.9 0.9 0.8 0.8 0.7 0.2
20 21 21 23 17 18 17 17 18 20 22 205
4.1 21 21 14 6.7 6.7 7.1 8.6 9.7 9.1 12 198
0.1 17 17 8.8 0.0 0.1 1.3 1.3 1.3 3.8 5.6 7.5
0.6 0.6 0.4 0.6 1.0 2.0 1.7 1.2 1.9 0.9 0.8 0.6
16 – – 8.8 9.8 9.8 8.7 8.7 8.7 11 9.3 7.5
4.0 -1.4 49 42 31 21 10 42 34 22 11 -15
-160 -166 -172 -181 -193 -206 -218 -231 -246 -260 -270 -345
21 21 25 34 34 35 35 35 51 53 53 94

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?